A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2

There is an urgent need for an oral drug for the treatment of mild to moderate outpatient SARS-CoV-2. Our preclinical and clinical study’s aim was to determine the safety and preliminary efficacy of oral TQ Formula (TQF), in the treatment of outpatient SARS-CoV-2. In a double-blind, placebo-controll...

Full description

Bibliographic Details
Main Authors: Hassan Bencheqroun, Yasir Ahmed, Mehmet Kocak, Enrique Villa, Cesar Barrera, Mariya Mohiuddin, Raul Fortunet, Emmanuel Iyoha, Deborah Bates, Chinedu Okpalor, Ola Agbosasa, Karim Mohammed, Stephen Pondell, Amr Mohamed, Yehia I. Mohamed, Betul Gok Yavuz, Mohamed O. Kaseb, Osama O. Kasseb, Michelle York Gocio, Peter Tsu-Man Tu, Dan Li, Jianming Lu, Abdulhafez Selim, Qing Ma, Ahmed O. Kaseb
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pathogens
Subjects:
COVID-19
TQ Formula
pandemic
coronavirus
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-0817/11/5/551

Internet

https://www.mdpi.com/2076-0817/11/5/551

Similar Items